{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["39"],"submitter":["Doulabi EM"],"pubmed_abstract":["Extracellular vesicles (EVs), whose main subtypes are exosomes, microparticles, and apoptotic bodies, are secreted by all cells and harbor biomolecules such as DNA, RNA, and proteins. They function as intercellular messengers and, depending on their cargo, may have multiple roles in cancer development. Thymidine kinase 1 (TK1) is a cell cycle-dependent enzyme used as a biomarker for cell proliferation. TK1 is usually elevated in cancer patients' serum, making the enzyme a valuable tumor proliferation biomarker that strongly correlates with cancer stage and metastatic capabilities. Here, we investigated the presence of TK1 in EVs derived from three prostate cancer cell lines with various p53 mutation statuses (LNCaP, PC3, and DU145), EVs from the normal prostate epithelial cell line RWPE-1 "],"journal":["Biochemistry and biophysics reports"],"pagination":["101761"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11246012"],"repository":["biostudies-literature"],"pubmed_title":["Increased levels of thymidine kinase 1 in malignant cell-derived extracellular vesicles."],"pmcid":["PMC11246012"],"pubmed_authors":["Doulabi EM","Larsson A","Harinck GM","Dubois L","Stalhandske P","Kamali-Moghaddam M","Lof L","Sinha TK"],"additional_accession":[]},"is_claimable":false,"name":"Increased levels of thymidine kinase 1 in malignant cell-derived extracellular vesicles.","description":"Extracellular vesicles (EVs), whose main subtypes are exosomes, microparticles, and apoptotic bodies, are secreted by all cells and harbor biomolecules such as DNA, RNA, and proteins. They function as intercellular messengers and, depending on their cargo, may have multiple roles in cancer development. Thymidine kinase 1 (TK1) is a cell cycle-dependent enzyme used as a biomarker for cell proliferation. TK1 is usually elevated in cancer patients' serum, making the enzyme a valuable tumor proliferation biomarker that strongly correlates with cancer stage and metastatic capabilities. Here, we investigated the presence of TK1 in EVs derived from three prostate cancer cell lines with various p53 mutation statuses (LNCaP, PC3, and DU145), EVs from the normal prostate epithelial cell line RWPE-1 ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Sep","modification":"2025-04-18T21:44:08.067Z","creation":"2025-02-19T02:34:19.156Z"},"accession":"S-EPMC11246012","cross_references":{"pubmed":["39006942"],"doi":["10.1016/j.bbrep.2024.101761"]}}